Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT
Mereo BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 361.1K | 533.43K | 8.79M | 3.56M | 832.01K | 674.99K | n/a | 462.39K | n/a | 308.58K | 50.64M | 25.13M |
Cost of Revenue | n/a | n/a | n/a | 257.29K | 274.84K | 216.92K | 172.9K | 3.53M | 1.23M | -322.93K | 337.5K | 85.55K | 231.19K | 520.52K | 154.29K | 25.55M | 12.5M |
Gross Profit | n/a | n/a | n/a | -257.29K | -274.84K | 144.18K | 360.53K | 5.26M | 2.34M | 1.15M | 337.5K | -85.55K | 231.19K | -520.52K | 154.29K | 25.09M | 12.63M |
Operating Income | -11.2M | -15.28M | -9.37M | -12.81M | -9.9M | -5.69M | -6.17M | -15.75M | -4.95M | -25.55M | -12.71M | -28.25M | -14.32M | -28.56M | -13.97M | -283.3K | -140.61K |
Interest Income | 659K | 881K | 983K | 559K | 617K | n/a | 202.46 | 373K | 307.5K | 614.15K | 741.36K | 224.25K | 989.81K | 1.27M | 1.27M | 1.31M | 1.31M |
Pretax Income | -12.89M | -7.05M | -15M | -12.26M | -8.95M | -5.8M | -6.32M | -14.72M | -5.97M | -19.02M | -9.3M | -25.79M | -13.07M | 4.55M | 2.25M | 15.14M | 7.52M |
Net Income | -12.89M | -7.05M | -15M | -12.26M | -8.95M | -6.05M | -6.56M | -13.6M | -5.51M | -17.66M | -9.35M | -24.83M | -12.58M | 867.99K | 429.19K | 16.79M | 8.33M |
Selling & General & Admin | 7.27M | 6.45M | 6.2M | 7.87M | 5.91M | 3.6M | 2.78M | 11.28M | 4.77M | 12.21M | 7.28M | 10.89M | 5.81M | 9.37M | 4.89M | 11.68M | 5.98M |
Research & Development | 3.93M | 8.82M | 3.17M | 4.95M | 3.99M | 2.89M | 3.19M | 9.74M | 3.95M | 13.67M | 6.55M | 17.27M | 8.75M | 18.67M | 9.23M | 13.69M | 6.79M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.2M | 15.28M | 9.37M | 12.81M | 9.9M | 6.39M | 7.03M | 21.02M | 8M | 25.87M | 8.9M | 28.16M | 12.31M | 28.04M | 3.36M | 25.37M | 3.81M |
Interest Expense | 180K | 375K | 353K | 331K | 310K | n/a | n/a | 1.03M | 800K | 1.43M | n/a | 2.2M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.5M | n/a | 5.81M | n/a | 6.47M | n/a | 4.46M | n/a | 5.68M | n/a |
Cost & Expenses | n/a | 15.81M | 9.37M | 12.81M | 9.9M | 6.61M | 7.2M | 24.54M | 9.22M | 25.55M | 9.23M | 28.25M | 12.54M | 28.56M | 3.51M | 50.92M | 16.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 244.47K | 235.58K | -1.12M | 453.5K | -1.36M | 45.22K | -952.73K | 482.75K | 3.68M | 1.82M | -1.64M | 816.07K |
Shares Outstanding (Basic) | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.37M | 138.37M | 125.69M | 124.79M | 112.84M | 114.47M | 116.78M | 116.78M | 116.73M | 107.83M | 98.92M | 83.36M |
Shares Outstanding (Diluted) | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.36M | 138.36M | 125.68M | 124.79M | 124.5M | 124.5M | 116.78M | 116.78M | 116.73M | 112.66M | 108.58M | 88.19M |
EPS (Basic) | -0.1 | -0.05 | -500.1 | -430.59 | -319.56 | -278.56 | -289.06 | -69.51 | -484.1 | -384.58 | -419.08 | -499.1 | -550.11 | 37.01 | 19.00 | 848.67 | 421.08 |
EPS (Diluted) | -0.1 | -0.05 | -500.1 | -430.59 | -319.56 | -278.56 | -289.06 | -69.51 | -484.1 | -424.08 | -456.09 | -499.1 | -550.11 | 37.01 | -700.14 | 773.15 | -72.01 |
EBITDA | -11.2M | -6.91M | -14.37M | -12.05M | -8.84M | -7.02M | -7.28M | -43K | -10.8M | -25.19M | -14.17M | -27.71M | -14.04M | -27.11M | -13.94M | 77.77K | 38.6K |
EBIT | n/a | -7.18M | -14.65M | -11.92M | -8.64M | -7.26M | -7.52M | -722K | -11.28M | -13.21M | -14.2M | -13.27M | -14.32M | -14.02M | -13.97M | -141.09K | -140.61K |
Depreciation & Amortization | n/a | 274K | 282K | 257K | 274.84K | 240.33K | 242.12K | 498.2K | 227K | 362.86K | 32.31K | 541.82K | 286.37K | 520.52K | 32.34K | 361.07K | 179.2K |